| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Abrdn Healthcare Investors (HQH) has 0 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. HQH is classified in the Capital Markets industry within the Financials sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 21, 2020 | Omstead Daniel R63 | President | Buy | 5,050 | $20.68 | $104,427.44 | +4.4% | |
| Sep 23, 2020 | Bailey Jeffrey Allen | Director | Buy | 490 | $20.39 | $9,991.10 | New | |
| May 21, 2020 | Omstead Daniel R63 | President | Buy | 5,000 | $21.01 | $105,054.00 | +4.7% | |
| Mar 17, 2020 | Omstead Daniel R63 | President | Buy | 6,800 | $16.24 | $110,411.60 | +7.1% | |
| Dec 26, 2018 | Omstead Daniel R63 | President | Buy | 6,300 | $17.14 | $107,970.66 | +8.0% | |
| Oct 25, 2018 | Omstead Daniel R63 | President | Buy | 5,500 | $20.43 | $112,344.10 | +7.5% | |
| Oct 17, 2018 | Omstead Daniel R63 | President | Buy | 3,882 | $21.78 | $84,534.43 | +5.6% | |
| Jan 25, 2018 | Kent Thomas M | Director | Buy | 1,100 | $24.19 | $26,604.82 | New | |
| Jan 6, 2016 | Gasperoni Timothy L | Senior Vice President Research | Buy | 862 | $28.98 | $24,978.17 | New | |
| Jun 29, 2015 | Stebbins Lucinda H | Director | Buy | 2,000 | $35.74 | $71,480.00 | +44.3% |